Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
How a racist genius created Silicon Valley by being a terrible boss

1h sfgate
William B. Shockley is shown with co-Nobel Prize in Physics winners Walter H. Brattain (center) and John Bardeen on April 11, 1956.
MCHP

6
Semiconductor Stocks, ETFs: Which Are The Best Wealth-Builders Now?

2018-08-17 seekingalpha - 1
Here is what the market-making community sees in the big-money-fund portfolio managers’ block-trade order activity (order flow).
MU AVGO BRCM MPWR MCHP

1
MCHP / Microchip Technology Inc. 8-K (Current Report)

2018-08-15 sec.gov
Document UNITED STATES
MCHP

119
Buffett Buys More Apple, GE Falls Further, & Turkey Weighs on Stocks | Free Lunch

2018-08-15 zacks - 1
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney discusses the morning’s top market headlines, including the effect of the Turkish crisis on U.S. stocks, GE’s historic low point, Corona’s new marijuana investment, and earnings from retail giant Macy’s.
STZ.B GEC GE M STZ MCHP CGC BRK.A TWMJF WEED AAPL GNE MS

1
Tuesday’s Biggest Winners and Losers in the S&P 500

2018-08-15 247wallst
Tuesday was a positive day for the broad U.S. markets, with all three major indexes positing a solid gain on the day. Crude oil was briefly positive during the session but ultimately ended flat. The S&P 500 sectors were all positive. The most positive sectors were consumer discretionary, financials and materials up 1.0%, 1.0%, and 0.8%, respectively. The worst performing sector was utilities up only 0.
MCHP AAP

9
Smartphone Suppliers Slide After Asia Peers' Earnings Disappoint

2018-08-15 theedgemarkets
(Aug 15): Smartphone suppliers were among the worst-performing semiconductor stocks Tuesday after two disappointing earnings reports from peers in Asia alarmed investors.
CRUS NVDA MCHP SWKS AMAT AAPL AVGO ADI MS BRCM

4
Washed Out Expectations Should Help MaxLinear From Here

2018-08-11 seekingalpha - 1
Dismal results in the Connected Home business lead to another weak quarter and a startlingly large reduction in third-quarter guidance as management seems to be "clearing the deck"
XLNX MXL AVGO IPHI MCHP

4
Bitcoin Burst To Hit Semiconductors Soon

2018-08-11 seekingalpha
As processor prices return to normal levels, we expect revenue to miss estimates in upcoming earnings announcements.
SOXX AMAT AVGO NVDA MCHP

1
Microchip Technology Incorporated (MCHP) CEO Steve Sanghi on Q1 2019 Results - Earnings Call Transcript

2018-08-10 seekingalpha
Good day everyone and welcome to this Microchip Technology First Quarter and Fiscal Year 2019 Financial Results Conference Call. As a reminder, today's call is being recorded.
ARW MCHP

1
Microchip Technology (MCHP) Beats Q1 Earnings and Revenue Estimates

2018-08-09 zacks
Microchip Technology (MCHP - Free Report) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.
PLNT GD EPE MCHP

1
MCHP / Microchip Technology Inc. 8-K (Current Report)

2018-08-09 sec.gov
Document UNITED STATES
MCHP

1
MCHP / Microchip Technology Inc. 10-Q (Quarterly Report)

2018-08-09 sec.gov
Document Table of Contents MCHP

4
Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2019

2018-08-09 globenewswire
CHANDLER, Arizona, Aug. 09, 2018 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today reported results for the three months ended June 30, 2018 as summarized in the following table:
MSCC MCHP

4
Microchip Technology Declares Quarterly Cash Dividend of 36.40 Cents Per Share

2018-08-09 globenewswire
CHANDLER, Ariz., Aug. 09, 2018 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) -- Microchip Technology Incorporated, a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announced that its Board of Directors has declared a quarterly cash dividend on its common stock of 36.40 cents per share. The dividend is payable on September 4, 2018 to stockholders of record on August 21, 2018.
MSCC MCHP

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 595017104